Premium
Is There Clear and Convincing Evidence of Cardiovascular Risk with Rosiglitazone?
Author(s) -
Kaul S,
Diamond GA
Publication year - 2011
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/clpt.2011.65
Subject(s) - counterpoint , citation , library science , medicine , center (category theory) , family medicine , sociology , computer science , pedagogy , chemistry , crystallography